- understand learn to live with the disease
- meet! discuss with others
- learn. information and resources
Meet, discuss & support other patients or families living with CAPS . Participate in group discussions. Contribute to topics, or just share what's on your mind
Conversations tagged medication
View: Translations (EN) Original language[ Expand all ]
-
Judith | Medication, FCAS, Rilonacept | published 22 days ago | Originally written in English Arcalyst/Rilonacept
I was diagnosed with FCAS earlier this year and have been on Arcalyst for about three months. At first it seemed like a miracle, but now I am experiencing some breaking out. My current dose is 160 mg a week. My rhematologist seems reluctant to increase the dose, but, frankly I am his only patient with this disease. So, we are both pretty much in the dark regarding treatment. Are there physicians that specialize in this disease? Does anyone have information that might assist me? I live in the northern part of Texas if that will help.
Thank you, Judith-
karend published 20 days ago | Originally written in EnglishDear Judith,
There are many experts for CAPS, but your area of Texas I am not aware of any at this time. I am currently in the hospital this week with a serious illness, but would like to talk with you when I am better about some options for doctors.
For now, I would recommend that your doctor consult with Dr Hoffman, as suggested at UCSan Diego on dosing. You can have a higher dose, and it has been researched. This will help you.
Also take a look at the website for arcalyst on Regeneron.com for info.
If you can send me an email to karen.nomidalliance.org it will be easier for me to connect you with doctor's, since I am in the hospital on an iPad for now. I then can answer you better when I am well. The good news is that there are 3 medications in the US that can help, in case you need to try a different option. All work very well for CAPS. We have info about all 3 medications on our website nomidalliance.org in the Learn area under CAPS treatments, and links to the drug info and websites for each medication.
Best wishes,
Karen
-
Judith published 18 days ago | Originally written in EnglishDear Karen,
I am truly sorry that you are in the hospital. I pray that you will recover quickly and go home soon!
I have tried to send you an email and have not been able to get it delivered.
I will give Dr Hoffman's info to my rheumatologist this week. Perhaps by my appointment in mid June
he will have some options on medications. Thank you so much.Sincerely,
Judith
-
karend published 17 days ago | Originally written in EnglishDear Judith,
So sorry! I was so sick I did not put my correct email address up! It is karen.nomidalliance.org@gmail.com or you can email through our contact us area on our website, nomidalliance.org So sorry for that, and thanks for the well wishes.
Please try to email it again! I will try to find some doctors closer to you. I do know that some people have found doctors in other areas of the state, but very few have found anyone with much experience with CAPS. There are some doctors in MO, OH, and GA, and also Dr Hoffman in San Diego, CA. Here is the info for DR Hoffman so your doctors can contact him:
Dr Hal Hoffman
9500 Gilman Drive, Room 5086
La Jolla, CA 92093-0635
Tel: (858) 534-2108
Fax: (858) 534-2110
E-mail: hahoffman@ucsd.eduHe has the most patients with FCAS, and also discovered the gene for CAPS! He has done research with all the current medications for CAPS, and would be a good resource for your doctor. He went to Med School at U.Texas at Galveston, so he may have some suggested doctors too.
I went home from the hospital with a PICC line to keep giving myself IV medications from home for the next 2-3 weeks. (I am also an RN). It is a long story, and the infection was very severe in an area that had previously had surgery and radiation for breast cancer, and I almost had to have more surgery for this! I do not have CAPS, (my middle son does)so this was not CAPS related. However,t I was so sick that my C-reactive protein, ESR and other labs were as high as many with severe CAPS, and boy did I feel horrible from inside my bones, muscles to my head from the inflammation, along with a high fever! I can only imagine what it must feel like for people with CAPS, which is different, but people suffer really bad every day.
I hope that we can connect and help you through email too.
Thanks,
Karen Durrant
nomidalliance.org
-
-
alicat2011 | Medication | published about 1 year ago | Originally written in English Canakinumab (Ilaris) muckle wells
Hi there.
My name is Alison and I would love to here from who is on Canakinumab (Ilaris) I'm on it, and next month will be my 5th dose. Also, if you have Muckle Wells, how has is your life improved?I really suffered with the rash, sore eyes and joint pains which had a major effect on my childhood and now touch wood thanks to Canakinumab (Ilaris) it is kept at bay
My 3 year old child also suffers and I am thinking about once she turns 4, starting her on treatment that way she will have a better childhood hopefully.
Reply to me with your thoughts...
-
karend published about 1 month ago | Originally written in EnglishDear Anna,
Have you had any success with getting your daughter tested for CAPS, or have you been able to get her the medication? There is another family that has just joined this group that is from Russia, and it would be nice to find out if you have had any success with getting treatment for your daughter.
Thanks,
Karen Durrant
-
AnnaKolev published about 1 month ago | Originally written in EnglishDear Karen
I know - she has already called me. We have sent uor blood tests to NIH USA and after 1-2 weeks the result will be ready. I hope that they will advice me therapy ( if anakinra with which dose it;s better to start with maybe ones a week or I know that in USA be tablet therapy ( asatioprin sometimes ) can be used. By the way we are preparing all document to ministry of health to get permissin to supply anakinra from abroad for our children. I also have seen about study programmes for Ilaris - but they send me to Moscow office - where on information. How much Ilaris cost? Just to understand if our government will manage to buy it for us ? Anna -
karend published about 1 month ago | Originally written in EnglishDear Anna,
I am very glad that the doctors at the NIH are helping you! This is good news. I had contacted them, but had not heard what had been done. It is also very good that you are working on trying to get permission from the government to have anakinra for your children. If you need help with this in any way, please let me know. You can email me directly at: karen.nomidalliance.org@gmail.com too. I have some forms that we can use to try to apply for the medication coverage, and I can try to help contact the drug company, but we will need to wait until your genetic testing is back. Your work with the government to get approval for this drug to be brought into Russia will be very helpful for your child, and many others too. Thank you!
I am very glad that you are also talking with the other family from Russia on this group! I am hopeful that you have also been put in touch with the other 2 families in Russia that are getting help for their children that have CAPS too.
As for the cost of Ilaris, it is very expensive, but in countries where the drug is approved, the insurance covers most of the cost, and there are patient assistance programs to also lower the cost to patients in the US. Anakinra is not as expensive, but it still costs a lot of money. In America, a month supply of anakinra based on 1 syringe a day of medication may cost around $20,000 a year, but Ilaris averages around $100,000 a year at the standard dosing. For some patients, they require higher doses of these medications. Here is an article about these drugs,a nd cost fro m2011: findarticles.com/p/articles/mi_hb4393/is_1...
Anakinra works out to be around $1600 for 28 syringes (4 weeks supply). For a young child, this is more than enough medication to cover their needs, even if they need a higher dose, but as they get older, they will need a higher dose..
One 150 mg vial of Ilaris costs around $16,000 but lasts for around 8 weeks for most patients, so it would cost around $8,000 a month, if you were getting Ilaris dosing every 8 weeks, or every 2 months (6 doses a year). Some patients need a much higher dosing of that medication, so the cost would be higher.
So Ilaris costs about 8 times MORE money than the anakinra per year. Anakinra is a daily injection. Both drugs work very well for patients, so I am hoping that your government will approve one of them to help your child.
Ilaris is approved by the European Medicines Agency for CAPS, but at this time anakinra is prescribed for CAPS as an off label prescription, which means that the drug is not officially approved at this time for CAPS by the medical agencies, as the drug was originally designed and approved for Rheumatoid Arthritis.
I hope this helps!
Karen
-
-
robpleticha | Medication | published 3 months ago | Originally written in English Drug halts organ damage in inflammatory genetic disorder
National Institutes of Health study suggests Kineret effective treatment for NOMID/CINCA
-
rdc-team | Medication | published over 2 years ago | Originally written in English Two new treatments with indication for CAPS
Information relating to two new treatments with an indication for the treatment of CAPS syndromes and which have recently received their Marketing Authorisation from the European Medecines Agency are available at the following URLs:
For Canakinumab (Ilaris):
www.ema.europa.eu/humandocs/Humans/EPAR/il...For Rilonacept (Arcalyst):
www.ema.europa.eu/humandocs/Humans/EPAR/ar...Access to these treatments will not immediately occur in each of the European Member States - this can take time. Best consult with your doctor or specialist.
In the USA the FDA provide information here:
For Canakinumab (Ilaris):
www.accessdata.fda.gov/scripts/cder/drugsa...For Rilonacept (Arcalyst):
www.accessdata.fda.gov/scripts/cder/drugsa...Finally just a word to say that the aim of this post is simply to provide information. The decision to take any of these treatments should be done in consultation with a medical professional.
-
rdc-team published over 2 years ago | Originally written in EnglishFurther information on Canakinumab (Ilaris®) in French published by the French Regulatory Authority - Haute Autorité de Santé is available at the following link:
This document explains the conclusions from the 3 phases of clinical trials, compares the treatment to other available (prescription and off-lable) treatments for each of the CAPS syndromes and details the level of reimbursement in France to patients.
-
CAPS community news
-
Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations.
show transcript
News, published 2 months ago
Cryopyrin-associated periodic syndromes (CAPS) represent a spectrum of CIAS1 gene-mediated autoinflammatory diseases characterized by recurrent systemic inflammation. The clinical spectrum of CAPS varies from mild to severe and includes the syndromes historically described as familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID). This article presents the largest cohort of patients with CAPS. The objective is to describe the pathogenesis, otolaryngologic, and audiologic manifestations of CAPS. -
Drug halts organ damage in inflammatory genetic disorder
show transcript
News, published 3 months ago
NIH study shows benefits of long-term Kineret therapy in people with NOMID -
Cuts in Ireland drastically impacting young man with CINCA's future
show transcript
News, published 8 months ago
Aisling McNiffe's voice crackles when she talks about her son's school prospects. Jack, a chirpy, fair-haired six-year old with a fondness for Toy Story movies, is the only person in the world known to have both Down's Syndrome and CINCA Syndrome, a degenerative disease that causes crippling headaches, severe arthritis, skin rashes, deafness and blindness. -
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
show transcript
News, published 10 months ago
The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice. -
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
show transcript
News, published 12 months ago
This study will evaluate the safety and effectiveness of anakinra (Kineret(Registered Trademark)) for treating patients with neonatal onset multisystem inflammatory disease (NOMID), also known as chronic infantile neurological, cutaneous and arthropathy (CINCA) syndrome. -
From the Australian Prescriber: New drugs Canukinumab
show transcript
News, published about 1 year ago
CanakinumabSome of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been limited published data and little experience in Australia of their safety or efficacy. However, the Editorial Executive Committee believes that comments made in good faith at an early stage may still be of value. As a result of fuller experience, initial comments may need to be modified. The Committee is prepared to do this. Before new drugs are prescribed, the Committee believes it is important that full information is obtained either from the manufacturer's approved product information, a drug information centre or some other appropriate source.
(Aust Prescr 2011;34:55-9)
Ilaris (Novartis)
vials containing 150 mg lyophilised powder for reconstitution
Approved indication: cryopyrin-associated periodic syndromes
Australian Medicines Handbook section 15.2.2 -
Más calidad de vida con biológicos en niños con patologías autoinflamatorias
show transcript
News, published about 1 year ago
En el segundo gran grupo, el del síndrome de la fiebre persistente, no mantienen estos episodios tan marcados. Aquí se ubica el síndrome de CAPS o criopirinopatías. Las criopirinas son las proteínas que ponen en marcha el mecanismo inflamatorio. -
“Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)”
show transcript
News, published about 1 year ago
Overall Status: RecruitingThis study will examine and test patients with neonatal onset multi-system inflammatory disease (NOMID) to learn more about the cause and course of the disease. It will study the disease signs and symptoms and the possible role of a gene called CIAS1, and it will develop a database to gather information on patients with NOMID in the United States and around the world. It will also serve as a screening protocol to offer eligible patients participation in a treatment protocol, if an appropriate one is available.
-
NOMID in the news in Canada
show transcript
News, published about 1 year ago
Such is the case for seven-year-old Brampton resident Michael Spiridakis, who suffers from neonatal onset multisystem inflammatory disease (NOMID), a genetic disorder that causes uncontrolled inflammation in multiple parts of the body. -
Wood River teen pushes recognition of rare diseases
show transcript
News, published about 1 year ago
Radney, 16, has a particular interest in the subject of rare diseases because almost four years ago she discovered she has Neonatal Onset Multisystem Inflammatory Disease, also called NOMID.....


